Back to Top
Go Back
Journal Photo for eBioMedicine
Peer reviewed only Open Access

eBioMedicine (eBioMedicine)

Publisher : The Lancet Group
Medicine Molecular Biology
e-ISSN 2352-3964
Issue Frequency Monthly
Est. Year 2014
Mobile 4401425462736
Country India
Language English
APC YES
Impact Factor Assignee Google Scholar
Email lancet-ads@elsevier.com

Journal Descriptions

eBioMedicine covers the spectrum of biomedical research, from preclinical studies with clear human relevance, through to proof-of-concept, first-in-human studies, and early phase clinical trials. We are dedicated to publishing original research that investigates the basic determinants of human health and disease, the discovery and characterization of new therapeutic targets and treatments, and the identification of biomarkers and diagnostic tools which may help researchers and clinicians better understand and monitor disease. We welcome studies that elucidate, or aim to modify, disease pathways and mechanisms—with the goal of advancing knowledge in any biomedical discipline with relevance to human health. We aspire to catalyse dialogue and collaboration between basic scientists, clinical researchers, and healthcare professionals; enhance the accessibility and applicability of basic research findings for health professionals; and promote a better understanding of clinical challenges for biomedical researchers.

eBioMedicine (eBioMedicine) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Medicine, Molecular Biology , Online , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2352-3964, Established: 2014,
  • Does Not Provide Crossref DOI
  • Indexed in: Scopus

  • Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing